Carlsmed (CARL) vs Cerus (CERS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cerus (CERS) has outperformed Carlsmed (CARL) over the past year, gaining 43.1% versus a gain of 5.8%. Cerus is the larger company by market cap ($448.4 million vs $386.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | CERS |
|---|---|---|
| Share price | $14.17 | $2.23 |
| Market cap | $386.86M | $448.39M |
| 1-day change | -1.47% | -2.84% |
| YTD return | +16.44% | +11.17% |
| 1-year return | +5.81% | +43.13% |
| 5-year return | — | -62.58% |
| EPS (TTM) | $-1.08 | $-0.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $3.47 |
| 52-week low | $8.50 | $1.38 |
| Distance from 52-week high | -17.76% | -35.88% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +35.51% | +130.56% |
| Average volume | 125.43K | 2.13M |
| Shares outstanding | 27.30M | 201.52M |
| Employees | 127 | 261 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERS has outperformed CARL by 37.3 percentage points over the past year.
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Health Care · Medical/Dental Instruments · 127 employees
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Health Care · Medical/Dental Instruments · 261 employees
CARL vs CERS FAQ
Which is bigger, Carlsmed or Cerus?
Cerus (CERS) is larger, with a market capitalization of $448.39M compared with $386.86M for Carlsmed (CARL).
Which stock has performed better over the past year, CARL or CERS?
CERS returned +43.13% over the past 12 months, compared with +5.81% for CARL (price return, excluding dividends). Past performance does not predict future results.
Are Carlsmed and Cerus in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.